Cover Image


Inhaled COPD Therapeutics

出版商 Greystone Research Associates 商品編碼 304992
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
吸入型慢性阻塞性肺病治療藥市場 Inhaled COPD Therapeutics
出版日期: 2014年06月04日 內容資訊: 英文





  • 設備、處方、市場發展
  • 確立的治療目標
    • 競爭的投藥形態
  • 處方趨勢
    • 治療策略
  • 促進成長的因素


  • 藥品處方和處方技術
    • 吸入設備設計要素
  • 乾燥粉末吸入器
  • 定量吸入器
  • 噴霧器
    • 投藥重現性
  • 活性化合物的穩定性
    • 新的設備技術


  • 新的處方技術
    • 便於病人使用的給藥/指導技術
    • 用戶確認/回饋/疾病管理
  • 組合(多藥)吸入器


  • 抗膽鹼促效劑
    • 抗膽鹼促效劑/SABA
  • 抗膽鹼促效劑/LABA
    • ICS/SABA
  • LABA
  • 其他重要/新興藥品等級


  • 法規及標準
  • 臨床試驗
  • 醫療經濟
  • 管理護理與醫療費付款者倡議


Product Code: CPD259K

COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral COPD inhalers, half of which are two-drug combination products, include design elements that attempt to address the unique and challenging treatment factors associated with COPD. The resulting devices are user-friendly and incorporate designed-in safety features, and in the process support the parallel goal of improved compliance. While not curative, these inhalable drug products provide patients with symptomatic relief while reducing the morbidity associated with this progressive disease.


  • Analyzes therapeutic drugs and pipeline candidates delivered via oral inhalers for treating COPD
  • Assesses inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors
  • Provides detailed assessments of inhaled drug targeted disease segments, growth prospects and market potential
  • Provides market data and forecasts for inhaled COPD therapeutic drugs to 2020
  • Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
  • Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners

Table of Contents

Executive Summary

COPD Therapeutics Market Dynamics

  • Devices, Formulations and Market Evolution
  • Established Therapeutic Targets
    • Competing Dosage Forms
  • Prescribing Trends
    • Therapeutic Strategies
  • Factors Driving Growth

COPD Technology & Product Development Factors

  • Drug Formulations & Formulation Technologies
    • Inhalation Device Design Factors
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
    • Dose Reproducibility
  • Active Compound Stability
    • Emerging Device Technologies

COPD Inhaler Design Factors

  • Novel Formulation Technology
    • Patient-friendly Administration/Coaching Technology
    • User Confirmation/Feedback/Disease Management
    • Embedded Electronics
  • Combination (multidrug) Inhalers

Inhaled COPD Product Analysis, Market Data & Forecasts

  • Anticholinergics
    • Anticholinergic/SABA
  • Antocholinergic/LABA
    • ICS/LABA
  • LABA
  • Other Important/Emerging Drug Classes

Market Factors

  • Regulations and Standards
  • Clinical Trials
  • Healthcare Economics
  • Managed Care and Payor Initiatives

Company Profiles

Back to Top